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ABSTRACT a-Sarcin is a cytotoxic protein that strongly interacts with acid phospholipid vesicles. This interaction exhibits a
hydrophobic component although a-sarcin is a highly polar protein. A peptide comprising the amino acid sequence corre-
sponding to the 1 16-139th segment of the a-sarcin cytotoxin has been synthesized by a standard fluoren-9-yl-methoxycarbonyl-
based solid phase method. Its primary structure is: (1 16)-NPGPARVIYTYPNKVFCGIIAHTK-(1 39). Two P3-strands have been
predicted in this region of a-sarcin, where the less polar stretches of the protein are found. The synthetic peptide interacts with
negatively charged large unilamellar vesicles of either natural or synthetic phospholipids. An apparent fragmentation of the
vesicles is produced by the peptide based on electron microscopy studies. The peptide promotes leakage of the intravesicular
aqueous contents and lipid mixing of bilayers. The packing of the phospholipid molecules is greatly perturbed by the peptide,
as deduced from the drastic changes induced by the peptide in cooperative properties associated with the phase transition of
the bilayers. At saturating peptide/phospholipid ratios, the phase transition of dimyristoylphosphatidylglycerol vesicles is abol-
ished. All of these effects are saturated at about 0.3 peptide/lipid molar ratio. The peptide adopts a mostly random structure
in aqueous solution. A conformation composed of a high proportion of antiparallel (-sheet is induced as a consequence of the
interaction with the phospholipid vesicles in opposition to trifluoroethanol that promotes a-helical peptide structures, as deduced
from circular dichroism measurements. The obtained results are discussed in terms of the potential involvement of the region
comprising residues 116-139 of a-sarcin in the hydrophobic interactions of this cytotoxic protein with membranes.
INTRODUCTION
The a-sarcin cytotoxin, secreted by the mold Aspergillus
giganteus, is a ribonuclease that cleaves a single phosphodi-
ester bond in a universal sequence of the 28S rRNA mole-
cule, promoting the inactivation of the ribosomes (see Wool
et al., 1992, for a review). The protein has been revealed to
be cytotoxic for many human tumor cell lines, inhibiting their
protein biosynthesis (Turnay et al., 1993). The process by
which a-sarcin enters cells has not been yet explained, as for
most protein toxins. No membrane protein receptors have
been found for a-sarcin, although it binds to the cell mem-
brane (Tumay et al., 1993). In addition, there are many re-
ports about the interaction of a-sarcin with phospholipid
model membranes. Thus, the protein perturbs the hydropho-
bic core of the bilayers promoting their lipid mixing as well
as leakage of the intravesicular aqueous contents (Gasset et
al., 1990; Mancheino et al., 1994); indeed, the protein is la-
beled with photoreactive probes located at the acyl chains of
the bilayer phospholipids (Gasset et al., 1991; Ofiaderra et al.,
1993). All these facts strongly suggest some kind of hydro-
phobic interaction between a-sarcin and the bilayers,
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although this is not easily predictable by simply considering
the amino acid sequence of a-sarcin. The protein is a highly
polar molecule with 150 amino acid residues (Sacco et al.,
1983), without stretches of non-polar residues long enough
to be apparently considered responsible for hydrophobic in-
teractions. The hydropathy profile of a-sarcin revealed that
the region exhibiting a somewhat less exposed character is
located around residues 120-140 (Martinez del Pozo et al.,
1988). Therefore, this protein segment could be involved in
the destabilization of bilayers produced by a-sarcin. On the
other hand, this protein shows a significant degree of se-
quence similarity with some fungal ribonucleases (RNases)
of the RNase Ti subfamily (Manchefio et al., 1995), although
these proteins contain about 40 amino acid residues less than
a-sarcin. The three-dimensional structures of some of these
ribonucleases are known and all of them are highly similar
to that of RNase Ti (Pace et al., 1991). Based on that simi-
larity, we proposed a structural model for a-sarcin, consid-
ering alignment of primary structures, three-dimensional
structures of the RNase Ti subfamily proteins, and second-
ary structure predictive methods (Manchento et al., 1995). A
hydrophobic ,3-sheet was thus predicted in a-sarcin, and it
was considered potentially involved in the hydrophobic in-
teractions of the protein with membranes. The abovemen-
tioned region of a-sarcin, residues 120-140, contributes to
such a p,-sheet. In fact, two antiparallel (3-strands were
predicted at this protein portion. To gain insights into the
mechanism of membrane destabilization promoted by
a-sarcin, we have considered the potential participation of
such a protein region in the effects caused in bilayers.
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Thus, we have synthesized a peptide containing the amino
acid sequence located between positions 116 and 139
of a-sarcin. This peptide ((116) Asn-Pro-Gly-Pro-Ala-Arg-
Val -Ile - Tyr-Thr-Tyr-Pro-Asn-Lys-Val-Phe-Cys-Gly-
Ile-Ile-Ala-His-Thr-Lys-NH2 (139)), the (116-139) peptide,
contains the two predicted (3-strands (120-125th and 130-
135th, sequence positions), which are separated and flanked
by potential (3-turn regions (Manchefio et al., 1995). We have
studied the interaction of this peptide with lipid model bi-
layers. The obtained results are in agreement with the po-
tential involvement of this protein region in the destabiliza-
tion of membranes promoted by a-sarcin. Although the
effects of a synthetic peptide may only partially mimic the
complexity of those of the parent protein, the studies per-
formed will improve the knowledge about the molecular
mechanism of the a-sarcin functionality. In addition, the ob-
tained results would be useful for comparative purposes be-
cause there are a number of natural peptides containing from
-10 to -30 amino acid residues, which promote a wide
variety of effects at the level of membranes (see Bemheimer
and Rudy, 1986; Cornut et al., 1993, for reviews), and their
composition might resemble that of the (116-139) peptide.
MATERIALS AND METHODS
Synthetic dimyristoylphosphatidylglycerol (DMPG), bovine brain phos-
phatidylserine (PS), N-(7-nitro-2-1, 3-benzoxadiazol-4-yl)-dimyristoyl-
phosphatidylethanolamine (NBD-PE) and N-(lissamine rhodamine B
sulfonyl)-diacylphosphatidylethanolamine (Rh-PE) were purchased from
Avanti Polar Lipids (Alabaster, AL). 8-Aminonaphthalene-1,3,6-trisulfonic
acid (ANTS) and N,N'-p-xylene-bis-pyridinium bromide (DPX) were pur-
chased from Molecular Probes (Eugene, OR). All other reagents were of
analytical grade. Buffers were prepared in Milli-RO water (Millipore, Mill-
ford, MA).
The (116-139) peptide was synthesized as amide in C-terminal on an
automated multiple peptide synthesizer (AMS 422, Abimed, Langenfeld,
Germany) by using the solid-phase procedure and standard 9-fluo-
renylmethoxycarbonyl (Fmoc) chemistry in a base of 25 ,umol. The syn-
thesis was carried out on an N-a-Fmoc-DMP resin (4-(2', 4'-dimeth-
oxyphenyl-Fmoc-amino-methyl)-phenoxy resin) (Novabiochem, La Jolla,
CA), with Fmoc-protected amino acids activated in situ with benzotriazole-
1-yl-oxy-tris-pyrrolidinophosphonium hexa-fluorophosphate in the pres-
ence of N-methyl morpholine and 20% piperidine/dimethylformamide for
deprotection. The protecting side chain groups were as follows: Ser, Thr and
Tyr (t-butyl-), Arg (pentamethylchroman sulfonyl-), Cys and His (triph-
enylmethyl-), Lys (t-butoxycarbonyl-). Peptide was cleaved from the resin
with 2.5% ethane dithiol (King et al., 1990) as scavenger, precipitated and
washed with cold methyl-tert-butyl ether, water-extracted, and lyophilized.
The peptide was subjected to further purification by reverse-phase high
performance liquid chromatography analysis on an Ultrasphere-ODS C18
column (10 X 150 mm) with a linear gradient water/35% acetonitrile in
0.1% trifluoroacetic acid. Fast atom bombardment mass spectrometry
yielded a mass/charge value of 2660.0 (calculated 2659). The amino acid
composition of the purified peptide exactly matches that expected. Peptide
concentration was determined from amino acid analysis and by absorbance
at 278 nm by using a molar extinction coefficient at pH 7.0 of 2700 M-' cm-'
(see Results). The peptide was hydrolyzed at 108°C in evacuated and sealed
tubes for 24 h, with 5.7 N HCI, containing 0.1% (w/v) phenol and norleucine
as internal standard. The analyses were performed on a Beckman System
6300 (Palo Alto, CA) amino acid analyzer.
Circular dichroism (CD) spectra were obtained on a Jovin Yvon Mark
III dichrograph (Longjumeau, France) fitted with a 250W xenon lamp. The
spectra were recorded at 0.2 nm/s scanning speed. Samples were analyzed
in either 0.05 or 0.01 cm optical path cells. CD results were expressed in
units of degree X cm2 X dmol[1 of amino acid residue. These values were
calculated on the basis of 110 as the mean residue weight for this peptide.
Fluorescence emission spectrum of the peptide was recorded at 1 nm/s
scanning rate on an SLM Aminco 8000 spectrofluorimeter (Urbana, IL), for
excitation at 275 nm wavelength. The optical path of the cells was 0.2 cm.
The slit widths for both excitation and emission beams were 4 nm. Fluo-
rescence emission was expressed in arbitrary units.
The different vesicles (except those for the leakage assay) were formed
by hydrating a dry lipid film with Mops buffer (50 mM Mops, pH 7.0,
containing 0.1 M NaCl and 1 mM EDTA) for 60 min at 37°C. The lipid
suspension was subjected to five cycles of extrusion through two stacked
0.1 ,um (pore diameter) polycarbonate membranes (Nuclepore, Costar;
Cambridge, MA) in an Extruder (Lipex Biomembranes Inc.; Vancouver,
BC, Canada). The average size of the vesicle population was 100 nm as
determined by Coulter counting. Phospholipid concentration was deter-
mined as described (Barlett, 1959)
The changes in turbidity at 360 nm of a vesicle suspension after addition
of a small aliquot of peptide were measured on a Beckman DU-8 thermo-
stated spectrophotometer (Palo Alto, CA). All vesicle suspensions (30,uM
final lipid concentration) were previously thermostated at the required tem-
perature. Control samples without peptide were also considered.
The lipid mixing was assayed according to Struck et al. (1981). Avesicle
population of DMPG or brain PS containing 1% NBD-PE (donor) and 0.6%
Rh-PE (acceptor) was mixed with unlabeled vesicles at 1:9 molar ratio (75
,uM final lipid concentration) in the Mops buffer. At zero time, a small
volume of peptide in the same buffer was added. The time course variation
of the fluorescence intensity at 530 nm for excitation at 450 nm (4 nm slit
width for both excitation and emission beams) was continuously monitored
on an SLM Aminco 8000 spectrofluorimeter. The percentages of energy
transfer (% ET) were calculated according to the expression % ET = (1 -
F/FO) X 100 where F is the final fluorescence intensity at 530 nm after
addition of peptide and Fo the fluorescence intensity at 530 nm of a vesicle
population ofDMPG orPS (75,M) containing 0.1% NBD-PE. To eliminate
the potential contribution of the sample turbidity to the fluorescence mea-
surements, 10 mm Glan-Thompson polarizers (SLM Aminco) (900/00) were
used.
Leakage of vesicle aqueous contents was measured by using the ANTS/
DPX assay as previously described by Ellens et al. (1985). Bovine brain PS
vesicles containing 12.5 mM ANTS, 45 mM DPX, 20 mM NaCl, 10 mM
Tris, pH 7.4, were prepared by five cycles of freeze-thawing and further
extrusion through two stacked 0.1 ,um (pore diameter) polycarbonate mem-
branes (Nuclepore). Vesicles were separated from uncapsulated materials on
Sephadex G-75 (Pharmacia, Uppsala, Sweden) by using Tris buffer (10mM
Tris, pH 7.4, containing 0.1 M NaCl and 1 mM EDTA) as elution buffer.
In a typical assay a small volume of peptide in the Tris buffer was added
to the vesicles (75 ,uM lipid concentration) at zero time. The variation of
fluorescence intensity measured through a 3-68 cutoff filter (>530 nm) upon
excitation at 386 nm was registered on an SLM Aminco 8000 spectrofluo-
rimeter. The 0 and 100% leakage were taken as the fluorescence intensity
of a PS vesicle suspension (75 F.M lipid concentration) before and after
addition of Triton X-100 at a final concentration of 1%, respectively. It has
been recently reported that the mode of mixing vesicle and peptide solutions
in the leakage assays can affect the kinetics of the process (Polozov et al.,
1994). Thus, the same amount of peptide can produce different leakage
curves depending on the peptide concentration of the initial solution. In the
present case, a single peptide stock solution was used and the stirring con-
ditions were not altered throughout the study.
Measurements of the fluorescence depolarization of 1,6-diphenyl-1,3,5-
hexatriene (DPH) (Aldrich, Milwaukee, WI) were made on an SLM Aminco
8000 spectrofluorimeter equipped with 10 mm Glan-Thompson polarizers.
Labeling of the vesicles with DPH was carried out as previously described
(Gavilanes et al., 1985). Peptide-vesicle mixtures were incubated for 1 h
above the transition temperature of the phospholipid, and later cooled down.
The fluorescence emission was measured at 425 nm for excitation at 365
nm, after equilibration of the samples at each required temperature.
For electron microscopy studies, samples of phospholipid vesicles (ob-
tained by extrusion through 0.1-,um pore diameter polycarbonate filters; see
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above) at 2.5 mg/ml lipid concentration, were applied to a glow-discharged
400 mesh Formvar-carbon-coated copper grid for 2 min. Excess fluid was
drawn away with filter paper. Samples were then negatively stained with 2%
(w/v) phosphotungstic acid at pH 7.0 and examined by using a Zeiss EM
902 (Jena, Germany) transmission electron microscope operating at 80 kV.
RESULTS
Spectroscopic characterization of the synthetic
(116-139) peptide
The UV absorbance spectrum of this peptide shows typical
features of the tyrosine chromophores. The absorbance maxi-
mum appears at 275 nm. The calculated extinction coeffi-
cient E0'% (278 nm, 1 cm) is 1.02, which is in agreement with
the presence of two tyrosine residues as single chromophores
at the aromatic region. The (116-139) peptide exhibits a
single fluorescence emission band centered at 304 nm, for
excitation at 275 nm, as would be expected from its amino
acid composition. The CD spectrum of the synthetic peptide
in the far UV (peptide bond region) is given in Fig. 1 A
(spectrum a). The percentages of secondary structure cal-
culated from this spectrum are: 11% antiparallel (3-structure,
210 220 230 240 nm
-4
-8
c ~~~~~~-12
[01220 X lo-3
FIGURE 1 (A) CD spectra of the synthetic peptide in: (a), 0-10% TFE;
(b), 20% TFE; (c), 30% TFE; (d), 40-60% TFE. ([0]) Mean residue weight
ellipticities are expressed in units of degree cm2 X dmol-1. Theoretical
values corresponding to the secondary structures deduced from the CD spec-
tra of the synthetic peptide in (-) aqueous solution and (A) 40% TFE,
according to Perczel et al. (1991). (B) Mean residue weight ellipticities at
220 nm, [0]220 in units of degree X cm2 x dmol[1, versus TFE concentration.
The peptide samples were dissolved in 50 mM Mops buffer, pH 7.0, con-
taining 0.1 M NaCl and 1 mM EDTA.
26% 3-turns, and 63% random. The method employed to
estimate the secondary structure contents from CD data
(Perczel et al., 1991), as most of these procedures, is based
on protein data, and these may not constitute the best basis
set to analyze peptides. But, it is clear that random confor-
mation is the predominant structure of the peptide by simply
considering the shape of the CD spectrum. The structure of
the synthetic peptide has also been analyzed under conditions
of enhanced intramolecular hydrogen bonding. It is well
known the effect of trifluoroethanol (TFE) in promoting in-
trachain hydrogen bonds in polypeptides, and it is thus con-
sidered a "membrane-mimicking" solvent. Its effect on the
conformation of the (116-139) peptide has been studied. The
peptide adopts helical conformation upon addition of TFE
(Fig. 1, A and B). There is no change in the CD spectrum up
to 10% TFE. A conformational change occurs in the 10-40%
TFE concentration range (Fig. 1 B). The CD spectrum d in
Fig. 1 A corresponds to the (116-139) peptide at 40-60%
TFE concentration. The secondary structure deduced from
this spectrum would be composed of 59% a-helix, 17%
,B-turns, and 24% random, with the same cautions as above.
Thus, the peptide can adopt a helical structure in spite of the
abundance of helix-destabilizing residues (e.g., Pro, Val, Ile,
Thr, or Gly). Finally, it is also worthy of mention that the CD
spectrum of the synthetic peptide in aqueous solution does
not show any modification in the 0.3-3.0 mg/ml (0.11-1.13
mM) concentration range.
Effects of the (116-139) peptide on model
phospholipid vesicles
The (116-139) peptide interacts with negatively charged
large unilamellar vesicles. This is clearly deduced by ob-
serving the transmission electron micrographs of peptide-
vesicle mixtures. Fig. 2, B and C show a preparation of
large unilamellar PS vesicles (Fig.2 A) treated with the
peptide. Two types of predominant structures are observed.
Negatively stained particles of <50 nm in diameter appear
upon the peptide treatment as predominant structures (ag-
gregates of these small particles can be also visualized).
These particles can be related to small vesicles, because
they are apparently formed by bilayer structures, although
non-bilayer-type ordination cannot be discarded based on
these results. In this regard, this type of particle may be re-
lated to the disk-shaped micelles produced by the lytic
peptide melittin (Dufourcq et al., 1986a, b). Larger struc-
tures also appear (aggregates of those particles of about 50
nm in diameter). An increase in the peptide to lipid molar
ratio results in the disappearance of the individual par-
ticles. At 60:1 lipid/peptide molar ratio, an amorphous
network of aggregated small particles is the most promi-
nent feature of the micrographs (Fig. 2 C). Thus, based on
the morphological changes, the peptide produces vesicle
fragmentation.
The interaction of the peptide with phospholipid vesicles
is also concluded by analyzing its effect on the thermotropic
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FIGURE 2 Negative stain trans-
mission electron micrographs of
phosphatidylserine vesicles (A), and
peptide-PS vesicles at 120:1 (B) and
60:1 (C) lipid to peptide molar ratio.
Bars correspond to: 100 nm in A and
150 nm in B and C.
behavior of DMPG vesicles. The synthetic peptide greatly
modifies the phase transition profile of the vesicles. Fig. 3
shows the anisotropy variation of DPH-labeled DMPG
vesicles upon addition of different amounts of the (116-139)
peptide. This study has been extended up to 60°C and no
other transitions are detected. The fluorescence anisotropy of
DPH monotonically decreases from the corresponding val-
ues obtained at 35°C. The main transition for the pure phos-
pholipid bilayers is observed at 23-24°C. There is no ap-
parent change in the transition temperature in the presence
of the peptide although it produces a progressive decrease of
the amplitude of the observed transition as the peptide to lipid
molar ratio increases. The anisotropy of DPH is slightly de-
creased below the transition temperature of the pure lipid
(r)
0.3
-E
D
C
0.2 ~ 0.2
B
A
/ ~~~~A(0)35
0.1 0.2 0.3 (R)
20 30 °C
FIGURE 3 Effect of the (116-139) peptide on the thermotropic behavior
of DMPG vesicles. (r) Anisotropy of DPH was measured at different tem-
peratures. Samples were in 50 mM Mops buffer, pH 7.0, containing 0.1 M
NaCl and 1 mM EDTA; 120 nmol of DMPG were used; the different
plots correspond to: (A) 0, (B) 0.05, (C) 0.10, (D) 0.15, and (E) 0.30
peptide/DMPG molar ratios. (Inset) A(r)35 measured at 350C of the
DPH-labeled DMPG vesicles as a function of the (R) peptide to lipid molar
ratio; A(r)35 values are calculated from the anisotropy at 35°C of the pure
lipid.
bilayers, whereas it is greatly increased above the transition.
This is interpreted as a decreased amplitude of a wobbling-
in-cone motion of the acyl chains. The values of the DPH
anisotropy (r) at 35°C can be used to monitor the effect of
the peptide on the thermotropic behavior of the lipid (Fig. 3,
inset). The effect of the peptide is maximum at about 3:1
lipid/peptide molar ratio (R = 0.3, peptide/lipid molar ratio),
the transition being totally abolished. a-Sarcin also decreases
the amplitude of the thermal transition of DMPG vesicles,
although to a lower extent than the (116-139) peptide.
Its effect was saturated at 50:1 lipid to protein molar ratio
and the phase transition was not abolished (Gasset et al.,
1989; 1991).
Addition of the peptide to a suspension of negatively
charged phospholipid vesicles promotes a moderate increase
in turbidity. The peptide produces a time-dependent increase
in the apparent absorbance at 360 nm of large unilamellar
DMPG vesicles. About 1 h is required for completion of the
absorbance variation, although 80% of the change is pro-
duced within the first 10 min of reaction. A summary of the
obtained results is given in Fig. 4 A. No turbidity variation
is observed up to about 10:1 DMPG/peptide molar ratio, the
maximum variation being obtained at about 3:1 lipid/peptide
molar ratio. When a-sarcin is assayed under identical con-
ditions, the maximum turbidity variation is 2.5-fold higher
than that produced by the synthetic peptide and is observed
at 50:1 DMPG/a-sarcin molar ratio (Gasset et al., 1989).
Such a turbidity increase was related to aggregation and fu-
sion of the large unilamellar vesicles promoted by the protein
(Gasset et al., 1989, 1990).
The (116-139) peptide destabilizes the DMPG vesicles
promoting lipid mixing as detected by using an energy trans-
fer assay (probe dilution). A summary of the obtained results
is given in Fig. 4 B. The dependence of the steady-state en-
ergy transfer (% ET) variation on the peptide concentration
also shows a sigmoidal behavior as occurred for the turbidity
change. The process is saturated at a -3-4 lipid/peptide mo-
lar ratio. The variation of the (% ET) in the lipid mixing
assays would be consistent with four- to fivefold dilution of
the probes. Considering that the labeled to unlabeled vesicle
populations ratio is 1:9, this observation indicates that the
peptide promotes extensive lipid mixing which, however, is
not complete, perhaps because some lipid is trapped within
aggregates. a-Sarcin promoted a complete lipid-mixing
based on energy transfer assays and electron microscopy
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FIGURE 4 (A) Variation of the turbidity (measured as the apparent ab-
sorbance at 360 nm) of a large unilamellar DMPG vesicle suspension (30
nmol/ml) produced by different amounts of the synthetic (116-139) peptide.
The turbidity values are plotted versus (R) peptide/lipid molar ratio. The
experiments have been performed at 37°C by continuously recording the
absorbance values in 1 cm optical path cells (1 ml total volume). The tur-
bidity values are calculated from the final absorbance values (1 h of reac-
tion). The peptide/vesicle system was in 50 mM Mops buffer, pH 7.0, con-
taining 0.1 M NaCl and 1 mM EDTA. (B) Lipid mixing promoted by the
synthetic (116-139) peptide. Results are expressed as percentage of energy
transfer (% ET), calculated from the fluorescence emission at 530 nm of the
NBD-PE probe (see Materials and Methods), versus (R) peptide/lipid molar
ratio. The assays have been performed in 50 mM Mops buffer, pH 7.0,
containing 0.1 M NaCl and 1 mM EDTA, at a constant temperature of 37°C.
The DMPG concentration was 75 nmol/ml, in 1 ml reaction mixture. (C)
Percentages of the maximum turbidity (0) and % ET (A) variation versus
peptide/DMPG molar ratio. The maximum turbidity value in (A) and the
maximum % ET variation (33%) in (B) have been considered as 100% for
each corresponding plot. (U) Percentages of the DPH anisotropy variation
at 35°C (taken from Fig. 2) versus peptide/lipid molar ratio; the maximum
r (at 35°C) variation has been considered as 100%. Vertical bars indicate
+SD values of three experiments.
studies, the saturating lipid/protein molar ratio being 50:1
(Gasset et al., 1990).
When the turbidity and % ET values are expressed as per-
centages of the corresponding maximum variations ob-
served, and the calculated values are plotted versus peptide/
DMPG molar ratio (Fig. 4 C), it can be observed that the two
processes parallel each other. It can be also observed that the
peptide modifies the lipid packing, as deduced from the
analysis of the lipid phase transition, at peptide/phospholipid
molar ratios where changes on neither turbidity nor % ET are
detected, although the three measurements reach completion
at the same peptide/lipid molar ratio (Fig. 4 C). It is worthy
of mention that the theoretical charge of the peptide at pH 7.0
would be around +4, according to its chemical composition.
The variation in turbidity, lipid mixing, and DPH anisotropy
become saturated at about 3:1 lipid/peptide molar ratio,
which corresponds to a negative to positive charge ratio of
-1.3. These facts suggest the involvement of a charge neu-
tralization in these processes.
The (116-139) peptide promotes leakage of intravesicular
aqueous contents. Addition of the peptide to a suspension of
large unilamellar PS vesicles containing entrapped ANTS/
DPX results in a time-dependent ANTS fluorescence in-
crease, consistent with the dequenching promoted by dilution
(%) of both probe (ANTS) and quencher (DPX) into the extrave-
sicular medium. The maximum leakage observed represents
80 70% of the ANTS fluorescence increase produced upon dis-
ruption of the vesicles with Triton X-100, considered as con-
60 trol for 100% leakage. The observed effect is dependent on
peptide concentration (Fig. 5 A). Both initial leakage rates
40 and extent of leakage show a similar dependence on peptide
(%) L
80
(%) ET
0.1 0.2 0.3
peptide/lipid molar ratio (R)
(%) L/s
7
5
13
FIGURE 5 (A) Leakage of aqueous contents promoted by the (116-139)
peptide. Bovine brain PS large unilamellar vesicles containing both ANTS
and DPX (see Materials and Methods) at 60 nmol/ml phospholipid con-
centration were treated with different amounts of peptide (total volume 1
ml). Experiments were performed at 37°C. (0) Values are expressed as %
leakage (% L) at 5 min after the addition of the corresponding amount of
peptide; 100% leakage was considered as the fluorescence emission value
obtained after addition of Triton X-100 (0.1% final concentration). (A)
Initial rates of leakage (% L/s) calculated from the kinetics plots of the
ANTS fluorescence variation. (R) Peptide to lipid molar ratio. (B) Lipid
mixing expressed in units of % ET of bovine brain PS large unilamellar
vesicles promoted by the (116-139) peptide. The assays were performed in
1 ml, containing 60 nmol phospholipid at a constant temperature of 37°C.
Other experimental details as in the legend to Fig. 4 B. (R) Peptide to lipid
molar ratio. Vertical bars indicate ±SD values of three experiments.
Mancheno et al. 2391
Biophysical Journal
concentration and are saturated at about 10:1 lipid/peptide
molar ratio. a-Sarcin also promoted leakage of intravesicular
contents, but this effect was saturated at 50:1 lipid/protein
molar ratio (Gasset et al., 1990).
The synthetic peptide also produces lipid mixing of PS
vesicles. A summary of the obtained results is given in Fig.
5 B. Increasing amounts of the (116-139) peptide produce a
slight increase on the observed lipid mixing up to a lipid/
peptide molar ratio of 5:1. In the 5-3 lipid/peptide molar ratio
range, an abrupt increase in the lipid mixing promoted is
observed. It can be observed that both processes, lipid mixing
and leakage, do not parallel (Fig. 5, A and B). This can also
be deduced from the corresponding kinetic analyses (Fig. 6).
The leakage is a faster process than the lipid mixing (-20-
fold in terms of initial rates). This suggests that the vesicles
leak first and the bilayers mix later.
Conformational changes of the (116-139) peptide
upon vesicle interaction
The conformation of the synthetic peptide is modified upon
interaction with the phospholipid vesicles. Fig. 7 shows the
CD spectra of vesicle-peptide mixtures. It is known that
sample turbidity might result in a potential distortion of the
CD signal. However, at the concentration of peptide and
vesicles and optical path (0.01 cm) herein used, no significant
alteration of the CD spectra is produced. In fact, controls with
ribonuclease A, a protein that does not interact with bilayers,
in the presence of vesicle dispersions at the same effective
absorbance as that of the peptide-vesicle samples, show no
significant alteration of the CD spectra in the considered
range (data not shown). The study performed indicates that
,3-structures are induced in the peptide upon vesicle inter-
action. The effect of the phospholipids on the peptide con-
formation becomes saturated at a -0.3 peptide/lipid molar
ratio, the same saturating ratio as that observed for the dif-
ferent actions promoted by the peptide on the vesicles. The
secondary structure calculated from the CD spectrum at 3:1
A
80
40 B
20
V l_
20 40 60 80 100 s
FIGURE 6 Kinetics of the (A) leakage and (B) lipid mixing induced by
the (116-139) peptide in large unilamellar PS vesicles, expressed as per-
centages of the corresponding maximum fluorescence variation. Both ki-
netic traces correspond to samples containing 60 nmol of PS vesicles and
15 nmol of peptide, at 37°C.
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FIGURE 7 CD spectra of the (116-139) peptide in the peptide bond re-
gion, at (a) 0, (b) 0.15, (c), 0.43; (d) 0.73, (e) 1.07, and (f) 3.00 lipid to
peptide molar ratios. [0], Mean residue weight ellipticities are expressed in
units of degree X cm2 X dmol1'. (Inset) Ellipticity at 210 nm, [01210, versus
lipid/peptide molar ratio. The dotted line corresponds to the [01210 value of
the sample at 3.0 lipid to peptide molar ratio (spectrum f). Samples were
dissolved in 50 mM Mops buffer, pH 7.0, containing 0.1 M NaCl and 1 mM
EDTA.
lipid/peptide molar ratio (Fig. 7 f) would be composed of
10% a-helix, 55% 13-structure, 8% 13-turns and 27% random.
As indicated for the peptide in aqueous solution, these values
should be cautiously considered, as they are determined from
a protein data basis. In addition, in this case the significant
ellipticity values used for the estimation of secondary struc-
ture have been considered in the 210-250 nm range, which
diminishes the reliability of the estimation. Nevertheless, the
increased 13-structure content is clearly deduced by simply
observing the shape of the CD spectra. This increase in the
13-structure content promoted by the phospholipids is in op-
position to the a-helical conformation promoted by TFE
(Fig. 1, A and B).
DISCUSSION
The cytotoxicity of a-sarcin depends on its ability to enter
the target cells, since it is an universal ribosome-inactivating
protein. Previous studies with model membranes have dem-
onstrated that the protein strongly interacts with bilayers,
exhibiting membrane-perturbing properties, which would be
related to its passage across membranes. In this context, there
is strong evidence of the involvement of hydrophobic inter-
actions in the action of the a-sarcin cytotoxin on lipid bi-
layers. Thus, the protein promoted large morphological
changes in the lipid bilayer, which suggested strong pertur-
bations of the phospholipid arrangement (Gasset et al.,
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1990). In addition, penetration of the protein into the hy-
drophobic core of the bilayers was deduced from the labeling
of a-sarcin observed in the presence of vesicles containing
photoreactive phospholipid analogues (Gasset et al., 1991;
Oniaderra et al., 1993). However, a-sarcin cannot be con-
sidered a hydrophobic protein. It only contains 31 amino acid
residues displaying a hydropathy index higher than that of
glycine (hydrophobic side chains) (Kyte and Doolittle, 1982)
among the 150 amino acids of the protein, and they are not
arranged in stretches of more than three consecutive residues
(Sacco et al., 1983). Therefore, it is not easy to propose the
participation of definite amino acid sequence regions of the
protein in its hydrophobic interactions with bilayers. Re-
cently, we have proposed a model for the structure of
a-sarcin (Manchefio et al., 1995). It was based on the se-
quence similarity that a-sarcin displays with the ribonucle-
ases of the RNase Ti subfamily. Since the three-dimensional
structures of these RNases are well known, the proposed
model included a folding for some of the ordered secondary
structure elements of a-sarcin. A hydrophobic 3-sheet com-
posed of four ,B-strands is the central part of such a model,
and therefore it would be a good candidate for the hydro-
phobic interactions involving a-sarcin. Two of these four
13-strands are consecutive in the primary structure of the pro-
tein, and they are located at the 120-135 sequence region of
a-sarcin. Thus, we have synthesized the (116-139) peptide
to evaluate the potential participation of the corresponding
a-sarcin region in the hydrophobic interactions of the protein
with bilayers. The synthetic peptide comprises the two con-
secutive 13-strands mentioned above, and also includes four
residues at each extreme that are predicted to be involved in
two respective 13-turns. The characterization of this peptide
has revealed that it is highly water-soluble, at least up to
a 3 mg/ml concentration, and it is mostly random based on
its low content of ordered secondary structure in aqueous
solutions.
The obtained results demonstrate that the (116-139) pep-
tide interacts with negatively charged large unilamellar lipid
vesicles of either natural or synthetic phospholipids, and
strongly suggest the existence of peptide-bilayer hydropho-
bic interactions. The effect of the peptide on the phase tran-
sition of lipid vesicles is drastic, and soundly suggests an
insertion of the peptide in the membrane. In fact, the peptide
abolishes the phase transition of the bilayer, as expected for
an integral molecule that restricts the mobility of the phos-
pholipid acyl chains. Abolition of the phase transition of
bilayers has been also reported for the interaction of car-
diotoxin II, a 60-residue peptide considered as a lytic factor,
with PG and PS vesicles (Faucon et al., 1983). Also, the
transition of dimyristoylphosphatidylcholine liposomes can
totally disappear in the presence of high amounts of
8-hemolysin, a 26-residue peptide (Bhakoo et al., 1985). The
synthetic (116-139) peptide also promotes an apparent
vesicle fragmentation. Disruption of phospholipid bilayers
by polypeptides into micelles or small vesicles has been also
reported. Thus, protein-induced fragmentation of lipid bi-
layers has been observed with serum apolipoproteins
(Brouillette et al., 1984; Anantharamaiah et al., 1985) and
myelin basic protein (Roux et al., 1994). A similar effect was
also reported for the peptides glucagon (Jones et al., 1978)
and melittin (Dufourc et al., 1986, 1989; Dufourcq et al.,
1986a,b). In this regard, melittin is a 26-residue lytic peptide
that exhibits some sequence similarity (-20%; data not
shown) with the (116-139) peptide. The leakage of vesicle
aqueous contents promoted by the (116-139) peptide may be
related to such a morphological change of the bilayers. These
observed effects can be modeled as follows. First, the posi-
tively charged peptide electrostatically interacts with the
negative surface of the vesicles. The net charge of the peptide
and its surrounding phospholipids becomes reduced and hy-
drophobic interactions can occur. Then, the peptide pen-
etrates the bilayer and perturbs the phospholipid acyl chain
core. These would be the first events, which would lead to
fragmentation of the vesicles and leakage of aqueous con-
tents. The resulting structures can be related to small vesicles,
based on the obtained electron micrographs. Micelles could
be also formed, but complete leakage of aqueous contents,
as would be expected for a detergent-like action, is not ob-
served, although non-vesicular peptide-lipid complexes can-
not be precluded from the obtained results.
The peptide also produces a modest increase in the light
scattering of the reaction mixture. This turbidity variation is
only observed at higher peptide concentrations than those
required for vesicle leakage. In addition, aggregation of large
vesicles produces greater turbidity variations as observed for
the entire protein (Gasset et al., 1989). These facts may sup-
port the notion that the absorbance variation promoted by the
(116-139) peptide was related to aggregation of the small
phospholipid-peptide vesicle-type structures (aggregates of
these particles are observed by electron microscopy; Fig. 2).
The peptide also induces lipid mixing of bilayers. Higher
peptide concentrations than those required for both leakage
of aqueous contents and alteration of the lipid packing are
also needed for detecting lipid mixing. Thus, the observed
lipid mixing of bilayers would occur within the aggregates
of the small vesicles. This may be supported by the fact that
no complete dilution of the fluorescence probes was detected
in the lipid mixing assays. In this regard, micelle-type struc-
tures would not be involved in lipid mixing. Thus, the probe
dilution would not be extended to the whole phospholipid
population, and the measured decrease in energy transfer in
the lipid mixing assay would be lower than the maximum
expected.
The dependence of both lipid mixing and light scattering
variation on peptide concentration may suggest the involve-
ment of peptide-peptide interactions. Concerning this pos-
sibility, no changes in secondary structure are observed in
concentrated aqueous solutions of the peptide, which would
discard an aggregated peptide form as bilayer-interacting
structure. But peptide-peptide interactions within the
complex with the vesicles cannot be discarded. In this sense,
the peptide contains one cysteine residue, which could
be potentially involved in the formation of a disulfide
bridge between two peptide monomers upon interaction
2393Mancheino et al.
2394 Biophysical Journal Volume 68 June 1995
with membranes. However, carboxyamido-methylation of
peptide-vesicle mixtures reveals that only free thiol are
present in these complexes (data not shown).
Finally, regarding the relation of the peptide to the na-
tive a-sarcin, the synthetic peptide promotes in the
vesicles qualitatively similar effects than a-sarcin. The
protein also produces leakage of aqueous contents, lipid
mixing of bilayers, and alteration of the lipid packing.
However, peptide and protein show significant differences,
mainly in terms of the morphological changes induced in
the membranes. Thus, a-sarcin produces large vesicle ag-
gregates and fused structures (Gasset et al., 1990), whereas
the peptide promotes apparent vesicle fragmentation. Re-
garding differences between the peptide itself and the pep-
tide as part of the protein, the corresponding region of
a-sarcin is involved in a disulfide bridge, which may result
in a modified behavior on interaction with vesicles. How-
ever, in spite of this, the extent and nature of the effects
promoted by the (116-139) peptide allow us to propose
that this protein region is a participant in the hydrophobic
interactions of a-sarcin with bilayers. The CD spectrum of
the (116-139) peptide in the presence of lipids reveals a
high content of f3-structure, as opposed to the helical con-
formation induced by TFE. TFE sometimes is considered a
helical promoter (Merutka and Stellwagen, 1989; Nelson
and Kallenbach, 1989); but it has been also described as a
helix enhancer (Sonnichsen et al., 1992) because a require-
ment for helix propensity was considered necessary to de-
velop this structure. However, there are also reports on
stable 13-strands in TFE (Narayanan et al., 1986). At any
rate, TFE is considered a "membrane-mimicking" solvent
because of its ability to promote intramolecular hydrogen
bonding as it would occur within the membranes. How-
ever, in this case it is clear that a different conformation is
observed upon interaction of the peptide with the bilayers.
Thus, although the synthetic peptide can adopt a helical
structure, this is not its preferred conformation when it in-
teracts with bilayers. In this regard, synthetic peptides cor-
responding to the lipid-binding domains of apo B-100
were rich in 13-structure when incubated with phospholip-
ids (Lins et al., 1994). These authors considered that their
observation was quite unusual, given that most peptides
after insertion into the lipid bilayer have been shown to
adopt mainly a helical conformation (Martin et al., 1993).
Lins et al. (1994) concluded that their data suggest that hy-
drophobic 13-sheet present in native apo B-100 is another
structure that strongly interacts with lipids. The (116-139)
peptide is also rich in 13-structure upon interaction with bi-
layers, and a similar conclusion can be drawn for a-sarcin:
the potential hydrophobic 13-sheet of the protein would be
involved in the hydrophobic interactions that characterize
the overall action of this cytotoxin on phospholipid
vesicles. However, there is no evidence that such a frag-
ment of a-sarcin acts as a membrane-interactive region in
vivo. In this regard, we have recently produced recombi-
nant a-sarcin (Lacadena et al., 1994), and the potential
preparation of a truncated form of a-sarcin lacking the
116-139 sequence may be of great interest.
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